Prevalence of benign tumors among patients with multiple sclerosis
Abstract
Keywords
Full Text:
PDFReferences
Hoglund RA, Maghazachi AA. Multiple sclerosis and the role of immune cells. World J Exp Med 4:27-37,
Kurtzke JF. A reassessment of the distribution of multiple sclerosis. Acta Neurol Scand 51:137-157, 1975.
Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58:840-846, 2005.
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-1452, 1983.
Anderson M, Hughes B, Jefferson M, Smith WT, Waterhouse JA. Gliomatous transformation and demyelinating diseases. Brain 103:603-622,1980.
Vieregge P, Nahser HC, Gerhard L, Reinhardt V, Nau HE. Multiple sclerosis and cerebral tumor. Clin Neuropathol 3:10-21, 1984.
Zimmerman HM, Netsky MG. The pathology of multiple sclerosis. Res Publ Assoc Res Nerv Ment Dis 28:271-312, 1950.
Khan OA, Bauserman SC, Rothman MI, Aldrich EF, Panitch HS. Concurrence of multiple sclerosis and brain tumor: clinical considerations. Neurology 48:1330-1333, 1997.
Currie S, Urich H. Concurrence of multiple sclerosis and glioma. Journal of neurology, neurosurgery, and psychiatry 37:598-605, 1974.
Aarli JA, Mork SJ, Myrseth E, Larsen JL. Glioblastoma associated with multiple sclerosis: coincidence or induction? Eur Neurol 29:312-316, 1989.
Markou A, Tsigou K, Papadogias D, Kossyvakis K, Vamvakidis K, Kounadi T, et al. A unique case of a benign adrenocortical tumor with triple secretion of cortisol, androgens, and aldosterone: development of multiple sclerosis after surgical removal of the tumor. Hormones 4:226-30, 2005.
Love S. Demyelinating diseases. J Clin Pathol 59:1151-1159, 2006.
Pender MP. The pathogenesis of primary progressive multiple sclerosis: antibody-mediated attack and no repair? J Clin Neurosci 11:689-692, 2004.
Naderi A. Prolactin-induced protein in breast cancer. Adv Exp Med Biol 846:189-200, 2015.
Suarez AL, Lopez-Rincon G, Martinez Neri PA, Estrada-Chavez C. Prolactin in inflammatory response. Adv Exp Med Biol 846:243-264, 2015.
Correale J, Farez MF, Ysrraelit MC. Role of prolactin in B cell regulation in multiple sclerosis. J Neuroimmunol 269:76-86, 2014.
Shelly S, Boaz M, Orbach H. Prolactin and autoimmunity. Autoimmun Rev 11:A465-470, 2012.
Peeva E, Venkatesh J, Michael D, Diamond B. Prolactin as a modulator of B cell function: implications for SLE. Biomed Pharmacother 58:310-319, 2004.
Etemadifar M, Najafi MA, Najafi MR, Alavi A, Nasr Z, Farokhi M, et al. Multiple sclerosis and hyperprolactinemia: a case-control study. Acta Neurol Belg 115:253-257, 2014.
Azar ST, Yamout B. Prolactin secretion is increased in patients with multiple sclerosis. Endocr Res 25:207-214, 1999.
Zhornitsky S, Yong VW, Weiss S, Metz LM. Prolactin in multiple sclerosis. Mult Scler 19:15-23, 2013.
Markianos M, Koutsis G, Evangelopoulos ME, Mandellos D, Sfagos C. Serum and cerebrospinal fluid prolactin levels in male and female patients with clinically-isolated syndrome or relapsing-remitting multiple sclerosis. J Neuroendocrinol 22:503-508, 2010.
Saha S, Gonzalez J, Rosenfeld G, Keiser H, Peeva E. Prolactin alters the mechanisms of B cell tolerance induction. Arthr Rheumat 60:1743-1752, 2009.
de Mello-Coelho V, Villa-Verde DM, Dardenne M, Savino W. Pituitary hormones modulate cell-cell interactions between thymocytes and thymic epithelial cells. J Neuroimmunol 76(1-2):39-49, 1997.
Matera L, Contarini M, Bellone G, Forno B, Biglino A. Up-modulation of interferon-gamma mediates the enhancement of spontanous cytotoxicity in prolactin-activated natural killer cells. Immunol 98:386-392, 1999.
Matera L, Mori M, Galetto A. Effect of prolactin on the antigen presenting function of monocyte-derived dendritic cells. Lupus 10:728-734, 2001.
Mitosek-Szewczyk K, Stelmasiak Z. Problems in diagnosing cranial base meningioma in patients with multiple sclerosis. Neurolog Sci 24:296-298, 2003.
Ludwig N, Keller A, Heisel S, Leidinger P, Rheinheimer S, Andres C, et al. Novel immunogenic antigens increase classification accuracy in meningioma to 93.84%. Int J Cancer 128:1493-1501, 2011.
Batay F, Al-Mefty O. Growth dynamics of meningiomas in patients with multiple sclerosis treated with interferon: report of two cases. Acta Neurochirurg 144:365-368, 2002.
Drevelegas A, Xinou E, Karacostas D, Parissis D, Karkavelas G, Milonas I. Meningioma growth and interferon beta-1b treated multiple sclerosis: coincidence or relationship? Neuroradiology 47:516-19, 2005.
Vieira RG, Vale TC, Rocha CF, Araujo CR, Lana-Peixoto MA, Brazilian Committee for T, et al. Meningioma after immunomodulation for multiple sclerosis. Arq Neuropsiquiatr 70:75-76, 2012.
Costa MF, Novis SA, Niemeyer Filho P, Pimentel ML, Novis RF, Duarte F. Multiple sclerosis, spinal cord ependymoma and intracranial meningioma: case report. Arq Neuropsiquiatr 58:1133-1137, 2000.
Schneider B, Pulhorn H, Rohrig B, Rainov NG. Predisposing conditions and risk factors for development of symptomatic meningioma in adults. Cancer Detect Prev 29:440-447, 2005.
Benson VS, Pirie K, Green J, Casabonne D, Beral V, Million Women Study C. Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort. Brit J Cancer 99:185-190, 2008.
Claus EB, Black PM, Bondy ML, Calvocoressi L, Schildkraut JM, Wiemels JL, et al. Exogenous hormone use and meningioma risk: what do we tell our patients? Cancer 110:471-476, 2007.
Wigertz A, Lonn S, Hall P, Auvinen A, Christen-
sen HC, Johansen C, et al. Reproductive factors and risk of meningioma and glioma. Cancer Epidem Biomarkers Prev 17:2663-2670, 2008.
Sena A, Couderc R, Vasconcelos JC, Ferret-Sena V, Pedrosa R. Oral contraceptive use and clinical outcomes in patients with multiple sclerosis. J Neurol Sci 317:47-51, 2012.
Villard-Mackintosh L, Vessey MP. Oral contraceptives and reproductive factors in multiple sclerosis incidence. Contraception 47:161-168, 1993.
Holmqvist P, Hammar M, Landtblom AM, Brynhildsen J. Age at onset of multiple sclerosis is correlated to use of combined oral contraceptives and childbirth before diagnosis. Fertil Steril 94:2835-2837, 2010.
Berman D, Miller NR. New concepts in the management of optic nerve sheath meningiomas. Ann Acad Med Singapore 35:168-174, 2006.
Bosch MM, Wichmann WW, Boltshauser E, Landau K. Optic nerve sheath meningiomas in patients with neurofibromatosis type 2. Arch Ophthalmol 124:379-385, 2006.
Fernandez MJ, Davis RP, Nora PF. Gastrointestinal lipomas. Arch Surg 118:1081-1083, 1983.
Jeong HK, Cho SB, Seo TJ, Lee KR, Lee WS, Kim HS, et al. Autoamputation of a giant colonic lipoma. Gut Liver 5:380-382, 2011.
Refbacks